Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on... read more
Clinical stage biopharma, Xynomic Pharma, filed the paperwork for a new $65 Million offering. The company is developing small molecule treatments for several different cancer types. It trades on... read more
Clinical stage biopharma RAPT Therapeutics filed the paperwork for its IPO on 6/5/19. The company is focused on developing therapies targeting immune drivers of cancer and inflammation. They... read more
Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotech Ltd (CHAIN) and... read more
While the pharmaceutical industry is a fast-growing sector of healthcare, different types of fraud are committed and reported to the government.... read more